Dolores Schendel

Meet Dolores Schendel

Schendel has been a member of the German Research Foundation, German Cancer Aid and the European Research Council, and developed her interest in tumor immunology while working at the Sloan-Kettering Institute in New York. In 2019, Medigene commenced a phase I/II trial of its first TCR-T immunotherapy against several blood cancers.